Insilico Medicine and Bora Pharmaceuticals announced a multi-target strategic alliance pairing Insilico’s AI-driven generative discovery capabilities with Bora’s manufacturing depth. The agreement is structured around definitive governance and execution terms, positioning Bora as an operational partner as Insilico continues advancing its pipeline using AI-discovered candidates.